TSX runs higher on rate cut expectations
DUBLIN - Investment giant BlackRock, Inc. has disclosed a 1.52% stake in Mural Oncology plc, according to a regulatory filing published Thursday.
The disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, reveals that BlackRock holds 263,551 ordinary shares in the oncology-focused company as of August 27, 2025.
The position consists of 263,536 relevant securities owned or controlled and 15 shares through cash-settled derivatives, according to the filing. BlackRock reported no short positions in Mural Oncology securities.
The disclosure also noted a stock loan transaction involving 10,100 ordinary shares of Mural Oncology, though no price was specified for this arrangement.
The filing was made as an opening position disclosure in accordance with Irish takeover regulations, which require public disclosure when an entity holds interests in relevant securities representing 1% or more of a company involved in a potential takeover situation.
The document did not provide details about any potential takeover activity involving Mural Oncology, nor did it indicate whether BlackRock intends to increase or decrease its position.
This information was released through a Form 8.3 filing with the Irish Takeover Panel, based on a press release statement issued by BlackRock.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.